Archive Newsletter

21. 12.12.24 -- How To Ensure 21 CFR Part 11 Compliance 12/12/2024

    12/12/24 Advancing RNA Newsletter

22. 12.12.24 -- All Eyes On Sustainability 12/12/2024

    12/12/24 Advancing RNA Newsletter

23. 12.11.24 -- Pushing Drug Development Forward With mRNA Expertise 12/11/2024

    12/11/24 Advancing RNA Newsletter

24. 12.11.24 -- Navigating the "Holy Trinity" of RNA Structure, Process, & Biology 12/11/2024
    12/11/24 Advancing RNA Newsletter
25. 12.04.24 -- How Platform Technologies Are Shaping The Gene Therapy Landscape 12/4/2024
    12/04/24 Advancing RNA Newsletter
26. 11.27.24 -- Tackling Standardization For mRNA Therapeutics 11/27/2024
    11/27/24 Advancing RNA Newsletter
27. 11.25.24 -- Oligonucleotide Synthesizers That Take You From Start To Finish 11/25/2024
    11/25/24 Advancing RNA Newsletter
28. 11.20.24 -- Tips For Addressing Vaccine Demand – Strategies For C&G And mRNA 11/20/2024

    11/20/24 Advancing RNA Newsletter

29. 11.20.24 -- Regulatory Considerations For mRNA Platforms 11/20/2024
    11/20/24 Advancing RNA Newsletter
30. 11.13.24 -- Strategies To Address FDA CMC Trends For mRNA Therapies 11/13/2024
    11/13/24 Advancing RNA Newsletter